Your browser doesn't support javascript.
loading
Factors associated with the development of second primary tumours in head and neck cancer patients.
Salcedo-Bellido, Inmaculada; Requena, Pilar; Mateos, Rocío; Ortega-Rico, Carmen; Olmedo-Requena, Rocío; Lozano-Lorca, Macarena; Arrebola, Juan Pedro; Barrios-Rodríguez, Rocío.
Afiliação
  • Salcedo-Bellido I; Departamento de Medicina Preventiva y Salud Pública, Universidad de Granada, Granada, Spain.
  • Requena P; Instituto de Investigación Biosanitaria de Granada (ibs.Granada), Granada, Spain.
  • Mateos R; Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, Spain.
  • Ortega-Rico C; Departamento de Medicina Preventiva y Salud Pública, Universidad de Granada, Granada, Spain.
  • Olmedo-Requena R; Instituto de Investigación Biosanitaria de Granada (ibs.Granada), Granada, Spain.
  • Lozano-Lorca M; Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, Spain.
  • Arrebola JP; Departamento de Medicina Preventiva y Salud Pública, Universidad de Granada, Granada, Spain.
  • Barrios-Rodríguez R; Departamento de Medicina Preventiva y Salud Pública, Universidad de Granada, Granada, Spain.
Eur J Cancer Care (Engl) ; 31(6): e13699, 2022 Nov.
Article em En | MEDLINE | ID: mdl-36117311
ABSTRACT

INTRODUCTION:

The development of second primary tumours (SPTs) is one of the main causes of low survival in patients with head and neck cancer (HNC). The aim of this study was to review the evidence about factors associated with developing SPTs in patients with HNC.

METHODS:

An updated systematic review was performed according to the Preferred Reporting Items for Systematic Reviews and Meta-Analysis guidelines, and the search was performed in Pubmed and Scopus. Only original articles with a cohort or case-control design were included. Article quality was assessed with the Newcastle-Ottawa scale.

RESULTS:

Thirty-six and two case-control studies were included, with quality medium (n = 5) to high (n = 33). Tobacco showed a significant association with SPT development, with risks ranging from 1.41 (95%CI 1.04-1.91) to 5.52 (95%CI 2.91-10.49). Regarding alcohol, risks ranged from 1.46 (95%CI 1.12-1.91) to 21.3 (95%CI 2.9-156). Location of the index tumour in the hypopharynx/oropharynx, absence of human papillomavirus and presence of a premalignant lesion also increased the risk of SPTs. More controversy was found for sex, age and other clinical factors of the tumour.

CONCLUSION:

Toxic lifestyle habits and clinical factors were associated with the risk of SPTs in HNC patients. These findings may improve individualised prevention strategies in its follow-up.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Segunda Neoplasia Primária / Neoplasias de Cabeça e Pescoço Tipo de estudo: Guideline / Observational_studies / Risk_factors_studies / Systematic_reviews Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Segunda Neoplasia Primária / Neoplasias de Cabeça e Pescoço Tipo de estudo: Guideline / Observational_studies / Risk_factors_studies / Systematic_reviews Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article